PureHealth completes EUR800m acquisition of Hellenic Healthcare Group

Image: PureHealth

PureHealth Holding, the largest healthcare group in the Middle East, has completed the acquisition of a 60% stake in Hellenic Healthcare Group (HHG), Greece and Cyprus’s leading private healthcare provider, for EUR800m.

The transaction values HHG at EUR1.3bn and marks a major step in PureHealth’s plan to build a globally connected, innovation-driven healthcare platform headquartered in Abu Dhabi.

The deal adds HHG’s 11 hospitals and 23 diagnostic centres to PureHealth’s network, expanding access to healthcare services for over 1.4 million patients each year.

HHG’s 6,900 healthcare professionals will now be part of PureHealth’s international ecosystem, reinforcing Abu Dhabi’s position as a global hub for healthcare excellence and investment.

Kamal Al Maazmi, chairman of PureHealth, said: “Finalising this transaction is an important milestone in our journey to create a globally connected healthcare platform. PureHealth has demonstrated the ability to source, execute and secure regulatory approvals in mature markets, reflecting its strengths and international credibility. With HHG, we are now expanding into new geographies, facilitating knowledge exchange, and fostering innovation that will enhance patient outcomes across our network. Importantly, this acquisition has been completed using PureHealth’s strong balance sheet, and we expect to recognise the financial upside from October 1.”

Shaista Asif, Group, CEO of PureHealth, added: “Welcoming HHG into the group accelerates our vision of delivering advanced, patient-centred healthcare across borders.”

PureHealth focused on expansion

The acquisition continues PureHealth’s pattern of disciplined international expansion. It follows the $1.2bn purchase of Circle Health Group, the UK’s largest independent hospital operator, in 2024, and a $500m investment in US-based Ardent Health Services in 2022, culminating in Ardent’s IPO on the New York Stock Exchange in 2024.

Alex Fotakidis, partner and Head of Greece at CVC, said: “We are proud to have supported HHG’s growth into Greece and Cyprus’s leading private healthcare provider. This partnership with PureHealth is a strong endorsement of HHG’s quality, scale, and future potential.”

Dimitris Spyridis, CEO of HHG, said: “Joining forces with PureHealth marks an important milestone for HHG. Together, we will accelerate innovation, enhance patient care, and strengthen our role as the leading healthcare provider in Greece and Cyprus. PureHealth has a large emphasis on technology, AI and healthcare of the future. Therefore we will be looking to integrate best practices not only in clinical practices, but also across the technology ecosystem.”

Following completion, CVC Capital Partners and HHG management retain a 40 per cent stake in HHG, ensuring continuity and supporting future growth.